Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A major depressive disorder (MDD) serious enough to warrant professional care affects approximately 16% of the general population during their life-time. Both the Epidemiological Catchment Area (ECA) study and the National Comorbidity Survey study have found that MDD is prevalent, with cross-sectional rates of up to 6.6%. Although this condition ranks first among reasons for psychiatric hospitalization (23.3% of total hospitalizations), it has been estimated that 80% of all persons suffering from it are either treated by non-psychiatric personnel or are not treated at all.
Depression is second only to hypertension as the most common chronic condition encountered in general medical practice. Depression is estimated to rival virtually every other known medical illness with regard to its burden of disease morbidity early in this millennium. With respect to physical function, depressed patients score, on average, 77.6% of normal function, with advanced coronary artery disease (CAD) and angina being 65.8% and 71.6%, respectively, and back problems, arthritis, diabetes, and hypertension ranging from 79% to 88.1%. MDD has also been characterized by increased mortality. In the general population, suicide accounts for about 0.9% of all deaths. Depression is the most important risk factor for suicide, with about 21% and 18% of the patients with recurrent depressive disorders and dysthymic disorder, respectively, attempting suicide.
Depressed patients often have co-morbid medical illnesses (e.g., arthritis, hypertension, backache, diabetes mellitus [DM], and heart problems). Similarly, the presence of one or more chronic medical conditions raises the recent (6-month) and life-time prevalence of mood disorders. Patients affected by chronic and disabling physical illnesses are at higher risk of depressive disorders, with rates being typically >20%. Among patients hospitalized for CAD, 30% present with at least some degree of depression. Patients with DM also have a two-fold increased prevalence of depression, with 20% and 32% rates in uncontrolled and controlled studies, respectively, conducted with depression symptom scales. Depression is also more common in obese persons than it is in the general population. At the Massachusetts General Hospital (MGH), the psychiatric consultant called to see a medical patient makes a diagnosis of MDD in approximately 20% of cases, making MDD among the most common problems seen for diagnostic evaluation and treatment. The prevalence of chronic medical conditions in depressed patients is higher regardless of the medical context of recruitment, with an overall rate ranging from 65% to 71% of patients. Several studies indicate that depression significantly influences the course of concomitant medical diseases. In general, the more severe the illness, the more likely depression is to complicate it. Some degree of depression in patients hospitalized for CAD is associated with an increased risk of mortality, and also with continuing depression for at least the first year after hospitalization. Proceeding to cardiac surgery while suffering from MDD, for example, is known to increase the chance of a fatal outcome. Depression in the first 24 hours after myocardial infarction (MI) was associated with a significantly increased risk of early death, re-infarction, or cardiac arrest. Even in depressed outpatients, the risk of mortality, chiefly as a result of cardiovascular disease, is more than doubled. The increased risk of cardiac mortality has also been confirmed in a large community cohort of individuals with cardiac disease who presented with either MDD or minor depression. Those subjects without cardiac disease but with depression also had a higher risk (from 1.5- to 3.9-fold) of cardiac mortality.
In patients with type 1 or 2 diabetes, depression was associated with a significantly higher risk of DM-specific complications (e.g., retinopathy, nephropathy, neuropathy, macrovascular complications, and sexual dysfunction). Data from the Hispanic Established Population for the Epidemiologic Study of the Elderly indicated that death rates in this population were substantially higher when a high level of depressive symptoms was co-morbid with DM (odds ratio, OR 3.84). Depression symptom severity is also associated with poor diet and with poor medication adherence, functional impairment, and higher healthcare costs in primary care patients with DM.
In acutely ill hospitalized older persons, the health status of patients with more symptoms of depression is more likely to deteriorate and less likely to improve during and after hospitalization. Under-recognition and under-treatment of depression in the elderly have been associated in primary care with increased medical utilization. Among the elderly (age ≥65 years), a significant correlation exists between depression and the risk of recurrent falls, with an OR of 3.9 when four or more depressive symptoms are present. These data are of particular importance because falls in the elderly are a well-recognized public health problem. Patients with cancer and co-morbid depression are at higher risk for mortality and for longer hospital stays. Unfortunately, despite the impact of depression on overall morbidity, functional impairment, and mortality, a significant proportion of those with depression (43%) fail to seek treatment for their depressive symptoms.
Failure to treat depression leaves the patient at risk for further complications and death. There is a clinical sense, moreover, that any seriously ill person who has neurovegetative symptoms, and who has given up and wishes that he or she were dead, is going to do worse than if he or she had hope and motivation. MDD, even if the patient is healthy in every other way, requires treatment. When a seriously ill person becomes depressed, the failure to recognize and to treat the disorder is even more unfortunate.
Prompt and effective treatment of medical co-morbidity is equally important for the outcome of depression. In a study of patients with DM, the severity of depression during follow-up was related to the presence of neuropathy at study entry, and to incomplete remission during the initial treatment trial. By the 10th year of insulin-dependent DM, roughly 48% of a sample of young diabetics developed at least one psychiatric disorder, with MDD being the most prevalent (28%). In addition to DM, other medical and neurologic conditions have been associated with an increased risk for MDD. For example, Fava and colleagues' review showed that MDD is a life-threatening complication of Cushing's syndrome, Addison's disease, hyperthyroidism, hypothyroidism, and hyperprolactinemic amenorrhea, and that treatment that primarily addresses the physical condition may be more effective than antidepressant drugs for such organic affective syndromes. A study of computerized record systems of a large staff-model health maintenance organization showed that patients diagnosed as being depressed had significantly higher annual health care costs and higher costs for every category of care (e.g., primary care, medical specialty care, medical inpatient care, and pharmacy and laboratory costs) than patients without depression. Depressive disorders are likely to cause more disability than are most other chronic diseases (e.g., osteoarthritis, DM), with a possible exception being MI.
The criteria for MDD according to the Diagnostic and Statistical Manual of Mental Disorders , 5th edition (DSM-5) should be applied to the patient with medical illness in the same way as to a patient without medical illness. The DSM-5 has a category for mood disorders “due to” another medical condition. A stroke in the left hemisphere, for example, is commonly followed by a syndrome clinically indistinguishable from MDD. It can now be referred to as a “major depression-like” condition when full criteria are met. Our recommendation is to diagnose a mood disorder using the DSM-5 criteria. A depressive disorder that does not meet full-threshold due to its duration or to the number of symptoms that cause clinically significant distress or impairment can now be diagnosed as an “Other Specified Depressive Disorder” in the DSM-5, which is often referred to as minor depression—a distinction that is important in the medically ill.
The DSM-5 classification of MDD involves clear-cut changes in affect, cognition, and neurovegetative functions. The common feature of MDD is the presence of depressed mood and/or a loss of interest/pleasure, which is accompanied by somatic and cognitive changes that significantly affect the individual's ability to function.
Diagnosis is crucial to treatment. Three questions face the consultant at the outset: (1) Does the patient manifest depression? (2) If so, is there an organic cause, such as use of a medication that can be eliminated, treated, or reversed? (3) Does it arise from the medical condition (e.g., Cushing's disease), and treatment of that condition will alleviate it, or must it be treated itself (e.g., post-stroke depression; PSD)?
Depression is a term used by most to describe even minor and transient mood fluctuations. It is seen everywhere and is often thought to be normal; therefore, it is likely to be dismissed even when it is serious. This applies all the more to a patient with serious medical illness: If a man has terminal cancer and meets the full criteria for MDD, this mood state is regarded by some as “appropriate.” Depression is used here to denote the disorder of MDD—a seriously disabling condition for the patient, capable of endangering the patient's life; it is not just an emotional reaction of sadness or despondency. If, while recovering from an acute stroke, a patient has a severe exacerbation of psoriasis, no one says that the cutaneous eruption is appropriate, even though the stress associated with the stroke has almost certainly caused it. Moreover, caregivers are swift to treat the exacerbation. When a patient with a history of MDD lapses into severe depression 1 month after beginning radiation therapy for an inoperable lung cancer, some may see a connection to the prior depressive illness and hasten to treat it. Far more common is the conclusion that anyone with that condition would be depressed. The majority of terminally ill cancer patients do not develop MDD no matter how despondent they feel. If a patient is hemorrhaging from a ruptured spleen, has lost a great deal of blood, becomes hypotensive, and goes into shock, no one calls this appropriate. Like shock, depression is a dread complication of medical illness that requires swift diagnosis and treatment.
Two assumptions are made here: (1) A depressive syndrome in a medically ill patient shares the pathophysiology of a (primary) major affective disorder, and (2) proper diagnosis is made by applying the same criteria. Patients who suffer from unipolar depressive disorders typically present with a constellation of psychological and cognitive ( Table 9-1 ), behavioral ( Table 9-2 ), and physical and somatic ( Table 9-3 ) symptoms. Because far less epidemiologic information is available on depression in the medically ill, the requirement that the dysphoria be present for 2 weeks or longer should be regarded as only a rough approximation in the medically ill. According to the DSM-5, at least five of the following nine symptoms should be present most of the day, nearly every day, and should include either depressed mood or loss of interest or pleasure:
Depressed mood, subjective or observed
Markedly diminished interest or pleasure in all, or almost all activities
Significant (more than 5% of body weight per month) weight loss or gain
Insomnia or hypersomnia
Psychomotor agitation or retardation that is observable by others
Fatigue or loss of energy
Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional), not merely about being sick
Diminished ability to think or concentrate, or indecisiveness
Recurrent thoughts of death (not just a fear of dying), recurrent suicidal ideation without a plan, or a suicide attempt or a specific plan for committing suicide.
Two questions (does the patient suffer from depressed mood? is there diminished interest or pleasure?) have a high sensitivity (about 95%), but unfortunately a low specificity (57%), for diagnosing MDD. Consequently, posing these two questions can be useful as a first approach to the patient who presents with risk factors for depression. However, further inquiry is required to establish the diagnosis. Although depressive disorders are frequently associated with medical illnesses, the DSM-5 considers that potential medical illnesses underlying depressive symptoms should be excluded before making the diagnosis of MDD. This hierarchical approach is typically ignored by clinicians, who tend to make the diagnosis of MDD even in the presence of co-morbid medical conditions that may be etiologically related to the condition itself. Nevertheless, the issue of differential diagnosis with medical diseases still exists, as patients may present with transient demoralization as a result of their physical illness or of fatigue or other cognitive and neurovegetative symptoms (but not fulfilling the criteria for MDD or even minor depression). For instance, weight loss and fatigue may also be associated with a variety of disorders (e.g., DM, cancer, thyroid disease). The medical and psychiatric history, together with the physical examination, should guide any further diagnostic work-up.
Depressed mood
Lack of interest or motivation
Inability to enjoy things
Lack of pleasure (anhedonia)
Apathy
Irritability
Anxiety or nervousness
Excessive worrying
Reduced concentration or attention
Memory difficulties
Indecisiveness
Reduced libido
Hypersensitivity to rejection or criticism
Reward dependency
Perfectionism
Obsessiveness
Ruminations
Excessive guilt
Pessimism
Hopelessness
Feelings of helplessness
Cognitive distortions (e.g., “I am unlovable”)
Preoccupation with oneself
Hypochondriacal concerns
Low or reduced self-esteem
Feelings of worthlessness
Thoughts of death or suicide
Thoughts of hurting other people
Crying spells
Interpersonal friction or confrontation
Anger attacks or outbursts
Avoidance of anxiety-provoking situations
Social withdrawal
Avoidance of emotional and sexual intimacy
Reduced leisure-time activities
Development of rituals or compulsions
Compulsive eating
Compulsive use of the internet or video games
Workaholic behaviors
Substance use or abuse
Intensification of personality traits or pathologic behaviors
Excessive reliance or dependence on others
Excessive self-sacrifice or victimization
Reduced productivity
Self-cutting or mutilation
Suicide attempts or gestures
Violent or assaultive behaviors
Fatigue
Leaden feelings in arms or legs
Difficulty falling asleep (early insomnia)
Difficulty staying asleep (middle insomnia)
Waking up early in the morning (late insomnia)
Sleeping too much (hypersomnia)
Frequent naps
Decreased appetite
Weight loss
Increased appetite
Weight gain
Sexual arousal difficulties
Erectile dysfunction
Delayed orgasm or inability to achieve orgasm
Pains and aches
Back pain
Musculoskeletal complaints
Chest pain
Headaches
Muscle tension
Gastrointestinal upset
Heart palpitations
Burning or tingling sensations
Paresthesias
The aforementioned DSM-5 symptoms may at first seem invalid in the medically ill. If the patient has advanced cancer, how can one attribute anorexia or fatigue to something other than the malignant disease itself? Four of the nine diagnostic symptoms could be viewed as impossible to ascribe exclusively to depression in a medically ill patient: sleep difficulty, anorexia, fatigue or energy loss, and difficulty concentrating. Endicott developed a list of symptoms that the clinician can substitute for, and count in place of, these four: fearful or depressed appearance; social withdrawal or decreased talkativeness; brooding, self-pity, or pessimism; and mood that is not reactive (i.e., the patient cannot be cheered up, does not smile, or does not react positively to good news). Although this method is effective, Chochinov and colleagues compared diagnostic outcomes using both the regular (Research Diagnostic Criteria) and the substituted criteria in a group of medically ill patients. If one held the first two symptoms to the strict levels—that is, depressed mood must be present most of the day, nearly every day, and loss of interest applies to almost everything—the outcome for both diagnostic methods yielded exactly the same number of patients with the diagnosis of MDD.
The first help comes from discovery of symptoms that are more clearly the result of MDD, such as the presence of self-reproach (“I feel worthless”), the wish to be dead, or psychomotor retardation (few medical illnesses in and of themselves produce psychomotor retardation; hypothyroidism and Parkinson's disease are two of them). Insomnia or hypersomnia can also be helpful in the diagnosis, although the patient may have so much pain, dyspnea, or frequent clinical crises that sleep is impaired by these events. The ability to think or concentrate, as with the other symptoms, needs to be specifically asked about in every case.
Mr. H, a 24-year-old graduate student without a psychiatric history reported some unusual aches during his annual physical. After a full work-up, it was determined that his A 1C was high, and upon fasting blood work, his blood sugar level was above diabetic levels (126 mg/dL) and he was thought to have type 2 diabetes (DM). His physician provided him with instructions to manage his newly diagnosed condition, including eating healthy, exercising, and monitoring serum glucose, and requested that he return to the office in 3 months.
Upon his return, Mr. H reported being unable to follow the doctor's instructions, and indeed his blood sugar levels remained above the targeted threshold. Mr. H also described being shocked by the news and feeling as though there was no hope. He also reported feeling tired all the time, sleeping poorly, and that he was concentrating poorly in classes. Due to these new symptoms, his physician requested a consultation to determine whether Mr. H was also struggling with depression, which might have been impacting his adherence to her instructions.
The consultant interviewed Mr. H and reviewed his medical records and medications. He was able to rule-out that his mood change was due to medication. Although the consultant was aware of normative reactions to a new diagnosis, he considered whether Mr. H's presenting concerns were a result of DM or co-occurring MDD. Mr. H already presented with sleep, concentration, and energy difficulties. Upon further questioning, Mr. H also reported considerable guilt over his present condition, stating “this is my fault” and described feelings of hopelessness and pessimism. He also described spending more time watching television alone and socializing less; he also found that the exercise and diet plan that his doctor suggested was too hard.
The consultant determined that Mr. H met criteria for MDD. His decision was based on the criteria of having five of nine MDD symptoms that were present most of the day, nearly every day. These also represented a change after his diagnosis and significant functional impairment. Of note, although some symptoms may be ascribed to DM, these symptoms would have also presented prior to his diagnosis. In addition, the presence of low self-esteem, guilt, hopelessness and apathy were more clearly a result of MDD. He conveyed these results to Mr. H's primary care physician and recommended starting adjunctive treatment for MDD.
Unfortunately, to some, a request for psychiatric consultation is tantamount to saying that physical symptoms are only “in your head” or are the result of malingering. Instead, depression is as much a somatic as a psychic disorder. The somatic manifestations of depression (e.g., insomnia, restlessness, anhedonia) may even be construed as proof to a patient that they have no “psychic” illness. “No, doctor, no way am I depressed; if I could just get rid of this pain, everything would be fine.” Persistence and aggressive questioning are required to elicit the presence or absence of the nine symptoms.
If the history establishes six of nine symptoms, the consultant may not be certain that three of them have anything to do with depression but may just as likely stem from a co-morbid medical illness. If the patient was found to be hypothyroid, the treatment of choice would not be antidepressants but judicious thyroid replacement. Usually, however, everything is being done for the patient to alleviate the symptoms of the primary illness. If this appears to be the case, our recommendation is to make the diagnosis of MDD and proceed with treatment.
Up to one-third of patients referred for depression have, on clinical examination, neither MDD nor minor depression. By far the most common diagnosis found among these mislabeled referrals at the MGH has been an organic mental syndrome. A quietly confused patient may look depressed. The patient with dementia or with a frontal lobe syndrome caused by brain injury can lack spontaneity and appear depressed. Fortunately, the physical and mental status examinations frequently reveal the tell-tale abnormalities. Another unrecognized state, sometimes called “depression” by the consultee and easier for the psychiatrist to recognize, is anger. The patient's physician, realizing that the patient has been through a long and difficult illness, may perceive reduction in speech, smiling, and small talk on the patient's part as depression. The patient may thoroughly resent the illness, be irritated by therapeutic routines, and be fed up with the hospital environment but, despite interior smoldering rage, may remain reluctant to discharge wrath in the direction of the physician or nurses.
When clinical findings confirm that the patient's symptoms are fully consistent with MDD, the consultant must still create a differential diagnosis of this syndrome. Could the same constellation of symptoms be caused by a medical illness or its treatment? Should the patient's symptoms be caused by an as yet undiagnosed illness, the last physician with the chance of detecting it is the consultant. Differential diagnosis in this situation is qualitatively the same as that described for considering causes of delirium (see Chapter 10 ). With depression, although the same process should be completed, certain conditions more commonly produce depressive syndromes and are worthy of comment.
Review of the medications that the patient is taking generally tells the consultant whether the patient is receiving something that might alter mood. Ordinarily, one would like to establish a relationship between the onset of depressive symptoms and either the start of, or a change in, a medication. If such a connection can be established, the simplest course is to stop the agent and monitor the patient for improvement. When the patient requires continued treatment, as for hypertension, the presumed offending agent can be changed, with the hope that the change to another antihypertensive will be followed by resolution of depressive symptoms. When this fails or when clinical judgment warrants no change in medication, it may be necessary to start an antidepressant along with the antihypertensive drug. The literature linking drugs to depression is inconclusive at best. Clinicians have seen depression following use of reserpine and steroids and from withdrawal from cocaine, amphetamine, and alcohol. Despite anecdotal reports, β-blockers do not appear to cause depression. It has been suggested that depression in some cases appears as a reaction to subclinical cardiovascular symptoms, so the differential diagnosis should also take into account medical conditions. The most common central nervous system (CNS) side effect of a drug is confusion or delirium, and this is commonly mislabeled as depression because a mental status examination has not been conducted.
Abnormal laboratory values should not be overlooked, because they may provide the clues to an undiagnosed abnormality responsible for the depressive symptoms. Laboratory values necessary for the routine differential diagnosis in psychiatric consultation should be reviewed. A work-up is not complete if the evaluation of thyroid and parathyroid function is not included. MDD is never “appropriate” (e.g., “This man has inoperable lung cancer metastatic to his brain and is depressed, which is appropriate”). MDD is a common and dread complication of many medical illnesses as they become more severe. To call it anything else is to endanger the patient and neglect one of the worst forms of human suffering. The disability associated with depressive illness is seldom recognized, yet it and mental illness in general show a stronger association with disability than with severe physical diseases. In general, the more serious the illness, the more likely the patient is to succumb to a depressive episode. Careful studies have found a high incidence of MDD in hospitalized medical patients. For more than 50 years, carcinoma of the pancreas has been associated with psychiatric symptoms, especially depression, which in some cases seems to be the first manifestation of the disease. Two carefully controlled studies have shown these patients to have significantly more psychiatric symptoms and major depression than patients with other malignancies of gastrointestinal origin, leading some to suspect that depression in this case is a manifestation of a paraneoplastic syndrome.
Direct injury to the brain can produce changes of affect that progress to a full syndrome of MDD. Morris and co-workers have intensively studied mood disorders that result from strokes. Left-hemisphere lesions involving the prefrontal cortex or basal ganglia are the most likely to be associated with post-stroke depression (PSD) and to meet criteria for MDD or dysthymia. Depressive symptoms appear in the immediate post-stroke period in about two-thirds of patients, with the rest manifesting depression by the 6th month. Additional risk factors for developing MDD were a prior stroke, pre-existing subcortical atrophy, and a family or personal history of an affective disorder. Aphasia did not appear to cause depression, but non-fluent aphasia was associated with depression; both seemed to result from lesions of the left frontal lobe. Although the severity of functional impairment at the time of acute injury did not correlate with the severity of depression, depression appeared to retard recovery. Among patients with left-hemispheric damage, those who were depressed showed significantly worse cognitive performance, which was seen in tasks that assessed temporal orientation, frontal lobe function, and executive motor function. Successful treatment of PSD has been demonstrated by double-blinded studies with nortriptyline and trazodone and been reported with electroconvulsive therapy (ECT) and use of psychostimulants. In fact, one study has shown that nortriptyline was more effective than fluoxetine in treating depressive symptoms in patients with PSD. Early and aggressive treatment of PSD is required to minimize the cognitive and performance deficits that this mood disorder inflicts on patients during the recovery period.
Right-hemisphere lesions deserve special attention. When the lesion was in the right anterior location, the mood disorder tended to be an apathetic, indifferent, state associated with “inappropriate cheerfulness.” However, such patients seldom look cheerful and may have complaints of loss of interest, or even worrying. This disorder was found in 6 of 20 patients with solitary right-hemisphere strokes (and in none of 28 patients with single left-hemisphere lesions).
Prosody is also a problem for those with a right hemisphere injury. Ross and Rush focused on the presentation of aprosodia (lack of prosody or inflection, rhythm, and intensity of expression) when the right hemisphere is damaged. A patient with such a lesion could appear quite depressed and be labeled as having depression by staff and family but simply lacks the neuronal capacity to express or recognize emotion. If one stations oneself out of the patient's view, selects a neutral sentence (e.g., “The book is red”), asks the patient to identify the mood as mad, sad, frightened, or elated, and then declaims the sentence with the emotion to be tested, one should be able to identify those patients with a receptive aprosodia. Next, the patient is asked to deliver the same sentence with a series of different emotional tones to test for the presence of an expressive aprosodia. Stroke patients can suffer from both aprosodia and depression, but separate diagnostic criteria and clinical examinations exist for each one.
Primary dementia, even of the Alzheimer's type, increases the vulnerability of the patients to suffering MDD, even though the incidence is not as high as it is in multi-infarct or vascular dementia. The careful post-mortem studies of Zubenko and colleagues supported the hypothesis that the pathophysiology of secondary depression is consistent with theories of those for primary depression. Compared with demented patients without depression, demented patients with MDD showed a 10- to 20-fold reduction in cortical norepinephrine levels.
Multi-infarct or vascular dementia so commonly includes depression as a symptom that Hachinski and associates included it in the Ischemia Scale. Cummings and co-workers compared 15 patients with multi-infarct dementia with 30 patients with Alzheimer's disease and found that depressive symptoms (60% vs 17%) and episodes of MDD (4/15 vs 0/30) were more frequent in patients with the former.
Patients with Parkinson's disease and Huntington's disease commonly manifest MDD. In fact, Huntington's disease may present as MDD before the onset of either chorea or dementia. The diagnosis is made clinically. Some have noted that as depression in the Parkinson's patient is treated, parkinsonian symptoms also improve, even before the depressive symptoms have subsided. This is especially striking when ECT is used, although the same improvement has been reported after use of tricyclic antidepressants (TCAs). Treatment of MDD in either disease may increase the comfort of the patient and is always worth a try. Because Huntington's patients may be sensitive to the anticholinergic side effects of TCAs, anticholinergic agents should be tried first.
Because HIV-1 is neurotropic, even asymptomatic HIV-seropositive individuals, when compared with seronegative controls, demonstrate a high incidence of electroencephalographic abnormalities (67% vs 10%) and more abnormalities on neuropsychological testing. The unusually high life-time and current rates of mood disorders in HIV-seronegative individuals at risk for AIDS demands an exceedingly high vigilance for their appearance in HIV-positive persons. Depression, mania, or psychosis can appear with AIDS encephalopathy, but the early, subtler signs (e.g., impaired concentration, complaints of poor memory, blunting of interests, lethargy) may respond dramatically to antidepressants, such as psychostimulants. The selective serotonin re-uptake inhibitors (SSRIs) (such as sertraline, fluoxetine, and paroxetine) have also been effective in the treatment of depression in HIV-positive patients. A small open trial also supports the use of bupropion in these patients.
We recommend that pharmacologic treatment be considered seriously whenever a patient meets criteria for either minor depression or MDD.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here